Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX – Get Free Report) saw a significant drop in short interest in December. As of December 15th, there was short interest totalling 18,100 shares, a drop of 10.0% from the November 30th total of 20,100 shares. Based on an average daily trading volume, of 14,100 shares, the days-to-cover ratio is currently […]
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX – Get Free Report) was the recipient of a large drop in short interest during the month of December. As of December 15th, there was short interest totalling 18,100 shares, a drop of 10.0% from the November 30th total of 20,100 shares. Currently, 0.2% of the company’s shares are sold short. […]
Cumberland Pharmaceuticals (NASDAQ:CPIX) Coverage Initiated by Analysts at StockNews com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
According to the report published by Allied Market Research, the global antimicrobial resistance market was valued at $4.6 billion in 2022, and is projected to reach $9.5 billion by 2032, registering a CAGR of 7.6% from 2023 to 2032. The report offers an in-depth analysis of the market size, emerging and current tre.
StockNews.com began coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX – Free Report) in a research note issued to investors on Monday. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Cumberland Pharmaceuticals Trading Up 1.2 % NASDAQ:CPIX opened at $1.74 on Monday. The company has a market capitalization of $25.93 million, a […]